Conditions in the PIK3CA-related overgrowth spectrum (PROS), such as CLOVES syndrome, fibroadipose hyperplasia, and megalencephaly-capillary malformation (MCAP), are very rare diseases. Doctors ...
The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group, focused ...
There is no cure for PIK3CA-related overgrowth spectrum, but several options are available to treat the root cause of the condition and help manage symptoms. These include targeted therapy, medication ...
The PIK3CA gene is mutated in nearly 40% of women with HR+/HER2- metastatic breast cancer and abnormal signaling in the PIK3CA pathway is related to tumorigenesis, progression, and therapeutic ...
To investigate the role of PIK3CA oncogene in tumorigenesis and development of esophageal cancer in Chinese patients at the levels of genetic mutation and epigenetics. Seventy six esophageal tumor ...
The outlook for someone with PIK3CA-related overgrowth spectrum (PROS) depends on factors that vary from person to person. Early intervention and treatment can improve the outlook and prevent ...
Effect of ABTL0812, a safe dual inhibitor of mTORC1/C2 and dihydrofolate reductase, on gemcitabine and docetaxel cytotoxicity in pancreatic and lung cancer cells. This is an ASCO Meeting Abstract from ...
If your child has been diagnosed with a PIK3CA-related overgrowth spectrum (PROS) disease, what can you expect in daily life? These rare diseases, caused by a mutation in the PIK3CA gene, can cause a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results